49 research outputs found

    A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study

    Get PDF
    A real-world population-based longitudinal study, aimed at determining the magnitude and duration of immunity induced by different types of vaccines against COVID-19, started in 2021 by enrolling a cohort of 2,497 individuals at time of their first vaccination. The study cohort included both healthy adults aged ≤65 years and elderly subjects aged >65 years with two or more co-morbidities. Here, patterns of anti-SARS-CoV-2 humoral and cell-mediated specific immune response, assessed on 1,182 remaining subjects, at 6 (T6) and 12 months (T12) after the first vaccine dose, are described. At T12 median anti-Spike IgG antibody levels were increased compared to T6. The determinants of increased anti-Spike IgG were the receipt of a third vaccine dose between T6 and T12 and being positive for anti-Nucleocapside IgG at T12, a marker of recent infection, while age had no significant effect. The capacity of T12 sera to neutralize in vitro the ancestral B strain and the Omicron BA.5 variant was assessed in a subgroup of vaccinated subjects. A correlation between anti-S IgG levels and sera neutralizing capacity was identified and higher neutralizing capacity was evident in healthy adults compared to frail elderly subjects and in those who were positive for anti-Nucleocapside IgG at T12. Remarkably, one third of T12 sera from anti-Nucleocapside IgG negative older individuals were unable to neutralize the BA.5 variant strain. Finally, the evaluation of T-cell mediated immunity showed that most analysed subjects, independently from age and comorbidity, displayed Spike-specific responses with a high degree of polyfunctionality, especially in the CD8 compartment. In conclusion, vaccinated subjects had high levels of circulating antibodies against SARS-CoV-2 Spike protein 12 months after the primary vaccination, which increased as compared to T6. The enhancing effect could be attributable to the administration of a third vaccine dose but also to the occurrence of breakthrough infection. Older individuals, especially those who were anti-Nucleocapside IgG negative, displayed an impaired capacity to neutralize the BA.5 variant strain. Spike specific T-cell responses, able to sustain immunity and maintain the ability to fight the infection, were present in most of older and younger subjects assayed at T1

    Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Reactivation of Epstein-Barr virus (EBV) infection may cause serious, life-threatening complications in immunocompromised individuals. EBV DNA is often detected in EBV-associated disease states, with viral load believed to be a reflection of virus activity. Two separate real-time quantitative polymerase chain reaction (QPCR) assays using SYBR Green I dye and a single quantification standard containing two EBV genes, Epstein-Barr nuclear antigen-1 (EBNA-1) and BamHI fragment H rightward open reading frame-1 (BHRF-1), were developed to detect and measure absolute EBV DNA load in patients with various EBV-associated diseases. EBV DNA loads and viral capsid antigen (VCA) IgG antibody titres were also quantified on a population sample.</p> <p>Results</p> <p>EBV DNA was measurable in ethylenediaminetetraacetic acid (EDTA) whole blood, peripheral blood mononuclear cells (PBMCs), plasma and cerebrospinal fluid (CSF) samples. EBV DNA loads were detectable from 8.0 × 10<sup>2 </sup>to 1.3 × 10<sup>8 </sup>copies/ml in post-transplant lymphoproliferative disease (n = 5), 1.5 × 10<sup>3 </sup>to 2.0 × 10<sup>5 </sup>copies/ml in infectious mononucleosis (n = 7), 7.5 × 10<sup>4 </sup>to 1.1 × 10<sup>5 </sup>copies/ml in EBV-associated haemophagocytic syndrome (n = 1), 2.0 × 10<sup>2 </sup>to 5.6 × 10<sup>3 </sup>copies/ml in HIV-infected patients (n = 12), and 2.0 × 10<sup>2 </sup>to 9.1 × 10<sup>4 </sup>copies/ml in the population sample (n = 218). EBNA-1 and BHRF-1 DNA were detected in 11.0% and 21.6% of the population sample respectively. There was a modest correlation between VCA IgG antibody titre and BHRF-1 DNA load (rho = 0.13, p = 0.05) but not EBNA-1 DNA load (rho = 0.11, p = 0.11).</p> <p>Conclusion</p> <p>Two sensitive and specific real-time PCR assays using SYBR Green I dye and a single quantification standard containing two EBV DNA targets, were developed for the detection and measurement of EBV DNA load in a variety of clinical samples. These assays have application in the investigation of EBV-related illnesses in immunocompromised individuals.</p

    ICAROS (Italian survey on CardiAc RehabilitatiOn and Secondary prevention after cardiac revascularization): Temporary report of the first prospective, longitudinal registry of the cardiac rehabilitation network GICR/IACPR

    Get PDF

    Self-regular boundary integral equation formulations for Laplace's equation in 2-D

    No full text
    The purpose of this work is to demonstrate the application of the self-regular formulation strategy using Green's identity (potential-BIE) and its gradient form (flux-BIE) for Laplace's equation. Self-regular formulations lead to highly effective BEM algorithms that utilize standard conforming boundary elements and low-order Gaussian integrations. Both formulations are discussed and implemented for two-dimensional potential problems, and numerical results are presented. Potential results show that the use of quartic interpolations is requitred for the flux-BIE to show comparable accuracy to the potential-BIE using quadratic interpolations. On the other hand, flux error results in the potential-BIE implementation can be dominated by the numerical integration of the logarithmic kernel of the remaining weakly singular integral. Accuracy of these flux results does not improve beyond a certain level when using standard quadrature together with a special transformation, but when an alternative logarithmic quadrature scheme is used these errors are shown to reduce abruptly, and the flux results converge monotonically to the exact answer. In the flux-BIE implementation, where all integrals are regularized, flux results accuracy improves systematically, even with some oscillations, when refining the mesh or increasing the order of the interpolating function. The flux-BIE approach presents a great numerical sensitivity to the mesh generation scheme and refinement. Accurate results for the potential and the flux were obtained for coarse-graded meshes in which the rate of change of the tangential derivative of the potential was better approximated. This numerical sensitivity and the need for graded meshes were not found in the elasticity problem for which self-regular formulations have also been developed using a similar approach. Logarithmic quadrature to evaluate the weakly singular integral is implemented in the self-regular potential-BIE, showing that the magnitude of the error is dependent only on the standard Gauss integration of the regularized integral, but not on this logarithmic quadrature of the weakly singular integral. The self-regular potential-BIE is compared with the standard (CPV) formulation, showing the equivalence between these formulations. The self-regular BIE formulations and computational algorithms are established as robust alternatives to singular BIE formulations for potential problems
    corecore